Cell mediated immunity and immunotherapy in ovarian cancer

Sean Kehoe

Research output: Contribution to journalArticlepeer-review

Abstract

The natural containment of ovarian cancer to the peritoneal cavity makes this mileau attractive for examining the immune status within a 'malignant environment'. Such investigations have yielded further insight into host-tumor responses. Immunological strategies have been employed in ovarian cancer either as single agents or combined with chemotherapy and although achieving responses have limited success. The understanding of cytokine inter-relationships, refinement of monoclonal antibody therapy and the potential genetic manipulation will enhance immunological strategies. This review will address aspects of our present knowledge of immune status in ovarian cancer, examine clinical studies incorporating immune agents and potential future therapies.
Original languageEnglish
Pages (from-to)451-458
Number of pages8
JournalInternational Journal of Oncology
Volume6
Issue number2
DOIs
Publication statusPublished - 1 Feb 1995

Keywords

  • Cell mediated
  • immunity
  • immunotherapy
  • ovarian cancer

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Cell mediated immunity and immunotherapy in ovarian cancer'. Together they form a unique fingerprint.

Cite this